$ESAB

ESAB Q2 Earnings Call Highlights

ESAB (NYSE:ESAB) discussed its Q2 earnings call and Eddyfi integration. Management said Eddyfi has high-single-digit growth, ~65% gross margins and ~30% EBITDA margins, with a ~$450 million commercial funnel. ESAB raised FY2026 outlook to core sales of ~$3.0-3.1B, adjusted EPS $5.40-5.50, and adjusted EBITDA $615-625M.

Original reporting
Published Aug 9, 2026, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESAB Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ESABBullishMed
01

Why it matters

The company raised FY 2026 guidance after Eddyfi closing, while acknowledging temporary EBITDA pressure from logistics and commodity inflation and outlining pricing and cost-reduction actions over coming quarters.

02

Market read

Traders can reprice ESAB based on the raised FY 2026 sales, EBITDA, EPS, and free-cash-flow conversion ranges, plus quantified temporary margin pressure and Eddyfi contribution.

03

What to watch

Eddyfi integration timing and conversion of a ~$450 million funnel are explicitly cautioned as time-consuming, which could delay order capture beyond the near-term 2027 ramp.

Relevance 8/10Novelty 7/10Timing: post-earnings call, guidance update for FY 2026

Background

ESAB discussed Q2 segment performance, margin drivers, and the impact of the Eddyfi transaction during its earnings call.

Company-level read

Ticker impact

$ESABBullishMedium confidence
Context

ESAB raised its full-year 2026 outlook after the Eddyfi closing, including core sales, EBITDA, EPS, and free-cash-flow conversion targets.

Expected impact

Likely positive bias for ESAB shares into the next few sessions as traders digest the raised 2026 targets and synergy/EBITDA contribution from Eddyfi.

Evidence & confidence

The article provides specific updated FY 2026 ranges (sales, organic growth, adjusted EBITDA, adjusted EPS, FCF conversion) and quantifies temporary EBITDA pressure and Eddyfi contribution, which are actionable for positioning.

Market effects

Welding and cutting equipment demand commentary (equipment vs consumables growth) and defense/energy strength may influence read-throughs for industrial fabrication supply chains.

Middle East conflict is cited as a temporary logistics-cost shock, with volumes down 10% to 11% in that region.

Geopolitical disruption and reconstruction demand are framed as longer-cycle offsets, potentially affecting regional order expectations for industrial inspection and welding solutions.

Counterpoint

The raised outlook still depends on pricing improvement toward ~3% and temporary price-cost neutrality unwinding, so margin upside may be less durable if commodity/logistics costs persist.

Key entities

  • ESAB

    Welding, cutting, and gas control technologies provider that raised FY 2026 outlook after Eddyfi closing.

  • Eddyfi

    Inspection-technology business whose contribution and integration timing are central to ESAB’s updated EBITDA and synergy expectations.

  • Brent Jones

    ESAB CFO who discussed margin impacts, financing effects on EPS, and cash-flow expectations.

  • Kambeyanda

    ESAB executive who discussed Eddyfi growth, commercial funnel size, and regional Middle East dynamics.

Related articles

$ESABMedAI 8/10

ESAB (ESAB) Q2 2026 Earnings Call Transcript

ESAB (ESAB) reported Q2 2026 core sales of $766 million, up 13% year over year, with 2.5% core organic growth. Adjusted EBITDA was $150 million, up 8%, and margin was 19.5%. Full-year guidance: core sales $3.0-$3.1B, adjusted EBITDA $615-$625M, adjusted EPS $5.40-$5.50, including Eddyfi. Middle East sales fell 10%-11% amid conflict.

$INFYMed

Aug 12: Markets Extend Losses as Tata Stocks, IT Shares Drag; Nifty Slips Below 24,450 – The Indian Awaaz

Indian benchmarks extended losses. The Nifty 50 fell 35.75 points, or 0.15%, to 24,435.95, and the Sensex dropped 187.90 points, or 0.24%, to 77,966.35. Tata stocks and IT shares weighed after Tata Sons chairman N Chandrasekaran said he will not seek reappointment. TCS fell 3.93% and Infosys 1.23%. India CPI inflation rose to 4.45% in July, from 4.38% in June.

$ESABMedAI 8/10

ESAB Q2 Deep Dive: Equipment Strength and Eddyfi Integration Drive Strategic Shift

ESAB reported Q2 revenue of $807.6 million, above analysts’ $787.2 million, with adjusted EPS of $1.33 versus $1.37 expected. Adjusted EBITDA was $151.4 million, slightly above estimates. Full-year adjusted EPS guidance of $5.45 and EBITDA guidance of $620 million both missed. Management cited equipment and automation strength and Eddyfi integration, while Middle East revenue fell due to geopolitical disruption and higher logistics costs.

$ESABMed

ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

$ESABHigh

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningspressrelease.htm EX-99.1 Document ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook

$ESABMed

Q4 Results 29th May Live: Asian Paints, IndiGo, NMDC, Glenmark Pharma, Ipca Lab, IREDA, Gujarat Gas, Natco Pharma, Inox Wind, Rubicon Research, BEML, NMDC Steel, JM Financial, Triveni Engg to announce

The article previews Q4 results from multiple Indian companies and highlights several earnings updates. Prime Focus reported standalone net profit of Rs 4.32 crore for March 2026 quarter vs Rs 16.11 crore loss a year earlier. Alkem Laboratories’ standalone net profit fell to Rs 217 crore from Rs 276.9 crore; it recommended a final dividend of Rs 10/share. It also cites Q4FY26 figures for ESAB India, Ecos Mobility, and Ivalue Infosolutions, plus early stock moves.